These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2509307)

  • 1. Development of a simple chromogenic factor VIII assay for clinical use.
    Wagenvoord RJ; Hendrix HH; Hemker HC
    Haemostasis; 1989; 19(4):196-204. PubMed ID: 2509307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a sensitive and rapid chromogenic factor IX assay for clinical use.
    Wagenvoord R; Hendrix H; Tran T; Hemker HC
    Haemostasis; 1990; 20(5):276-88. PubMed ID: 2127037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of clotting factor VIII activity in mammals using the one-stage clotting and the chromogenic methods].
    Lutze G; Lutze G; Kutschmann K; Schröpel M
    Berl Munch Tierarztl Wochenschr; 2002; 115(7-8):297-302. PubMed ID: 12174728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple and accurate microplate assay for the determination of factor VIII activity.
    Carlebjörk G; Oswaldsson U; Rosén S
    Thromb Res; 1987 Jul; 47(1):5-14. PubMed ID: 3116712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrophotometric method for the assay of human blood coagulation factor VIII.
    van Dieijen G; van Dieijen-Visser MP; Franssen J; Hemker HC
    Haemostasis; 1987; 17(1-2):14-24. PubMed ID: 3110024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of a chromogenic substrate method for determination of factor VIII activity.
    Rosén S; Andersson M; Blombäck M; Hägglund U; Larrieu MJ; Wolf M; Boyer C; Rothschild C; Nilsson IM; Sjörin E
    Thromb Haemost; 1985 Dec; 54(4):818-23. PubMed ID: 3937277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of coagulation factor VIII activity by a chromogenic substrate method on STA, an automated coagulation analyzer.
    Kleinveld HA; Andersson NE; van Voorthuizen H; den Hartog J; de Groot PG
    Scand J Clin Lab Invest; 1999 Aug; 59(5):335-41. PubMed ID: 10533845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates.
    Rosén S
    Thromb Haemost; 2001 Oct; 86(4):1132-3. PubMed ID: 11686346
    [No Abstract]   [Full Text] [Related]  

  • 9. Issues with the assay of factor VIII activity in plasma and factor VIII concentrates.
    Lundblad RL; Kingdon HS; Mann KG; White GC
    Thromb Haemost; 2000 Dec; 84(6):942-8. PubMed ID: 11154139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A chromogenic assay allows reliable measurement of factor VIII levels in the presence of strong lupus anticoagulants.
    de Maistre E; Wahl D; Perret-Guillaume C; Regnault V; Clarac S; Briquel ME; Andre E; Lecompte T
    Thromb Haemost; 1998 Jan; 79(1):237-8. PubMed ID: 9459356
    [No Abstract]   [Full Text] [Related]  

  • 11. Assaying the circulating factor VIII activity in hemophilia A patients treated with recombinant factor VIII products.
    Mikaelsson M; Oswaldsson U
    Semin Thromb Hemost; 2002 Jun; 28(3):257-64. PubMed ID: 12098085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation and chromogenic assays of factor VIII activity: general aspects, standardization, and recommendations.
    Barrowcliffe TW; Raut S; Sands D; Hubbard AR
    Semin Thromb Hemost; 2002 Jun; 28(3):247-56. PubMed ID: 12098084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-stage vs. chromogenic assays in haemophilia A.
    Potgieter JJ; Damgaard M; Hillarp A
    Eur J Haematol; 2015 Feb; 94 Suppl 77():38-44. PubMed ID: 25560793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of the thrombin generation test components to measure potency of factor VIII concentrates.
    Jha NK; Shestopal SA; Gourley MJ; Woodle SA; Liang Y; Sarafanov AG; Weinstein M; Ovanesov MV
    Haemophilia; 2016 Sep; 22(5):780-9. PubMed ID: 27038076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International comparative field study evaluating the assay performance of AFSTYLA in plasma samples at clinical hemostasis laboratories.
    St Ledger K; Feussner A; Kalina U; Horn C; Metzner HJ; Bensen-Kennedy D; Blackman N; Veldman A; Stowers A; Friedman KD
    J Thromb Haemost; 2018 Mar; 16(3):555-564. PubMed ID: 29274194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a procedure for potency assessing of a high purity factor VIII concentrate--comparison of different factor VIII coagulant assays and effect of prediluent.
    Mazurier C; Parquet-Gernez A; Goudemand M
    Thromb Haemost; 1990 Oct; 64(2):251-5. PubMed ID: 2125374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of phospholipids on the assessment of factor VIII activity.
    Mikaelsson M; Oswaldsson U; Sandberg H
    Haemophilia; 1998 Jul; 4(4):646-50. PubMed ID: 9873808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three methods for measuring factor VIII levels in plasma.
    Chandler WL; Ferrell C; Lee J; Tun T; Kha H
    Am J Clin Pathol; 2003 Jul; 120(1):34-9. PubMed ID: 12866370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIII test in reference preparations: compensation for different dilutions.
    König H; Rosenkranz S; Nawrot R; Hunfeld A; Seitz R
    Pharmeur Sci Notes; 2005 Aug; 2005(1):11-3. PubMed ID: 17687888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative field study on the utility of a BDD factor VIII concentrate standard in the estimation of BDDr Factor VIII:C activity in hemophilic plasma using one-stage clotting assays.
    Ingerslev J; Jankowski MA; Weston SB; Charles LA;
    J Thromb Haemost; 2004 Apr; 2(4):623-8. PubMed ID: 15102018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.